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Breban and Blower (2005) challenge our use of the
word ‘‘threshold’’ to name the ‘‘Reinfection Threshold’’
(Gomes et al., 2004a) on the basis that this is not a
bifurcation point. Assuming that a misnomer of the
concept would invalidate its implications, they deduce
that our results have no epidemiological consequences.
Here we explain the terminology but, more importantly,
we emphasize that the choice of name does not affect the
implications of the concept. We assert that the
epidemiological behaviour associated with R0 ¼ 1=s
remains unchanged.
The recognition that partial immunity divides the
transmissibility axis into two distinct modes of transmis-
sion emerged almost simultaneously from two studies: a
systematic analysis of microparasite transmission under
suboptimal immunity (Gomes et al., 2004a); and a
representation of the transmission dynamics of tubercu-
losis leading to a hypothesis for the widely debated
variable efﬁcacy of the bacille Calmette-Gue´rin (BCG)
vaccine (Gomes et al., 2004b). The two studies overlap
through a modiﬁed SIR modelUN 7981
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RdS
dt
¼ ð1 vÞe R0IS  eS,
dI
dt
¼ R0IðS þ sRÞ  I , ð1Þ
where S and I are the proportions of fully susceptible
and infected individuals, respectively, and R ¼ 1 S 
I is the proportion recovered with partial immunity.
In units of average duration of infection, births and
deaths occur at a rate e; and a proportion v of the
population is vaccinated at birth to enter compartment
R: Individuals in S are infected at a rate, R0I ; and
individuals in R are infected at a reduced rate, sR0I ;
where 0psp1: The existence of these two distinct rates
of infection is the key to our ﬁndings.
The endemic equilibria of model (1) are represented in
Fig. 1 as a function of the basic reproduction number,
R0: The proportion of infectious individuals is repre-
sented in linear (a) and logarithmic (b) scales, and the
four curves correspond to different vaccination cover-
age: v ¼ 0; 0.67, 0.89, 1, from left to right. For the
purpose of illustration we chose s ¼ 0:25; but the
conclusions that follow remain valid for any value
between 0 and 1. We set e ¼ 0:0012; which is attained
under a life expectancy of 70 years and an average
duration of infection of 1 month. Shorter infectious
periods would enhance the effects that follow.
Breban and Blower (2005) carry out a bifurcation
analysis of the v ¼ 0 model, and correctly conclude that
87
RR
EC
TE
D 
PR
OO
F
1
3
5
7
9
11
13
15
17
19
21
23
25
27
29
31
33
35
37
39
41
43
45
47
49
51
53
55
57
59
61
63
65
67
69
71
73
75
77
79
81
83
85
87
89
91
93
95
97
99
101
103
105
107
109
111
ARTICLE IN PRESS
YJTBI : 3923
105
104 
103 
102 
101 
100
pr
op
or
tio
n 
in
fe
ct
io
us
, I
 
0
0.2
0.4
0.6
pr
op
or
tio
n 
in
fe
ct
io
us
, I
 
0 1 2 3 4 5 6 7
0
0.2
0.4
0.6
0.8
1
basic reproduction number, R0 
va
cc
in
at
io
n 
co
ve
ra
ge
, v
 
controllable
     zone 
uncontrollable
       zone 
(a)
(b)
(c)
Fig. 1. Endemic equilibria, and potential impact of vaccination as a function of transmissibility illustrated for s ¼ 0:25: (a, b) proportion infectious
in linear and logarithmic scale, respectively, under four levels of vaccination coverage: v ¼ 0; 0.67, 0.89, 1, from left to right. The non-vaccination line
marks the epidemic threshold (R0 ¼ 1), and the full-vaccination line (dashed) marks the reinfection threshold (R0 ¼ 1=s). (c) vaccination coverage
required to eliminate infection in the controllable (light) zone. Mass vaccination is generally ineffective in the uncontrollable (dark) zone.
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COthe only bifurcation point is the epidemic threshold,R0 ¼ 1 (Kermack and McKendrick, 1927). However, we
note that all curves show a marked increase in the
prevalence of infection as R0 increases across R0 ¼ 1=s:
In Fig. 1(a) this effect is more evident, and in Fig. 1(b)
we observe that vaccination can eliminate infection for
1oR0o1=s; while this is ineffective for R041=s: Fig.
1(c) shows the vaccination coverage required to
eliminate infection in the controllable (light) zone
(1oR0o1=s) while this is impossible in the uncontrol-
lable (dark) zone (R041=s). We attribute this behaviour
to a bifurcation in the reinfection submodel that takes
place at R0 ¼ 1=s: The reinfection submodel is obtainedby setting v ¼ 1; and the associated equilibria are thus
represented by the dashed curve in Fig. 1(b). Conse-
quently, we term R0 ¼ 1=s as the ‘‘reinfection thresh-
old’’. When vo1; the reinfection threshold is no longer a
bifurcation point, but remains as a useful value to
interpret levels of infection and to determine the
potential impact of vaccination programmes.
The reinfection threshold is determined by the degree
of protection conferred by a previous infection or
vaccine, whichever is more protective. Therefore, its
position can be manipulated by more potent vaccines
widening the controllable zone. The reinfection thresh-
old sets the targets for vaccine development and use, and
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M.G.M. Gomes et al. / Journal of Theoretical Biology ] (]]]]) ]]]–]]] 3its quantitative characterization cannot be overempha-
sized. This is perhaps the most important message for
public health.29
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Our ﬁnal remarks refer to the last paragraph of
Breban and Blower (2005). Their ﬁnal sentence is
misleading.1 The authors restate that no epidemiological
consequences can be assigned to the reinfection thresh-
old because R0 ¼ 1=s is not a bifurcation point. They
claim that our ﬁndings concerning reinfection reduce to
a nonlinear increase in the prevalence of infection as R0
increases, as previously reported by Blower et al. (1998)
and Feng et al. (2000). This is not the case. As described
above we have analysed the form of the nonlinear
increase and the variability in the effectiveness of
vaccination. We have detected a bifurcation in the
reinfection submodel at R0 ¼ 1=s; we have shown that
levels of infection of the full epidemic model increase by
two orders of magnitude as R0 increases across a vicinity
of 1=s; we have demonstrated that the same vaccine can
eliminate infection if R0o1=s and appears impotent ifUN
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1Breban and Blower (2005) refer to tuberculosis and quote from a
previous article: ‘‘the higher the susceptibility to reinfection the easier
it will be to achieve eradication’’ (Blower et al., 1998). The full sentence
in the original article is: ‘‘For any particular (endemic equilibrium)
incidence rate, the higher the susceptibility to reinfection the easier it
will be to achieve eradication’’ (Blower et al., 1998). The two
statements have different meanings. The ﬁrst could imply that
increasing susceptibility to reinfection with M. tuberculosis (e.g. by
spreading AIDS) would bring us closer to eradicating tuberculosis.
This does not make sense. The second applies solely to the
interpretation of a given endemic equilibrium: the higher the
reinfection, the lower the R0 required for a given endemic equilibrium
and, in principle, lower R0 implies easier eradication.R041=s: We named this critical value the reinfection
threshold and discussed its implications for vaccine
development and public health policy.OO
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